Northern Trust Corp Dynavax Technologies Corp Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Northern Trust Corp holds 1,322,022 shares of DVAX stock, worth $16.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,322,022
Previous 1,308,641 1.02%
Holding current value
$16.7 Million
Previous $14.7 Million 0.21%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$10.05 - $11.61 $134,479 - $155,353
13,381 Added 1.02%
1,322,022 $14.7 Million
Q2 2024

Aug 14, 2024
SELL
$10.73 - $12.58 $551,114 - $646,133
-51,362 Reduced 3.78%
1,308,641 $14.7 Million
Q1 2024

May 14, 2024
SELL
$11.7 - $14.98 $514,331 - $658,520
-43,960 Reduced 3.13%
1,360,003 $16.9 Million
Q4 2023

Feb 13, 2024
SELL
$13.09 - $14.98 $559,793 - $640,619
-42,765 Reduced 2.96%
1,403,963 $19.6 Million
Q3 2023

Nov 13, 2023
BUY
$12.64 - $14.99 $298,594 - $354,108
23,623 Added 1.66%
1,446,728 $21.4 Million
Q2 2023

Aug 11, 2023
BUY
$9.85 - $13.17 $563,449 - $753,363
57,203 Added 4.19%
1,423,105 $18.4 Million
Q1 2023

May 15, 2023
SELL
$9.44 - $11.88 $21,551 - $27,122
-2,283 Reduced 0.17%
1,365,902 $13.4 Million
Q4 2022

Feb 13, 2023
BUY
$10.27 - $13.29 $452,455 - $585,504
44,056 Added 3.33%
1,368,185 $14.6 Million
Q3 2022

Nov 14, 2022
BUY
$9.93 - $17.44 $48,776 - $85,665
4,912 Added 0.37%
1,324,129 $13.8 Million
Q2 2022

Aug 12, 2022
BUY
$7.45 - $12.83 $1.19 Million - $2.06 Million
160,183 Added 13.82%
1,319,217 $16.6 Million
Q1 2022

May 13, 2022
SELL
$9.75 - $14.44 $453,833 - $672,138
-46,547 Reduced 3.86%
1,159,034 $12.6 Million
Q4 2021

Feb 08, 2022
SELL
$13.17 - $20.94 $166,560 - $264,828
-12,647 Reduced 1.04%
1,205,581 $17 Million
Q3 2021

Nov 15, 2021
BUY
$9.16 - $19.83 $24,722 - $53,521
2,699 Added 0.22%
1,218,228 $23.4 Million
Q2 2021

Aug 13, 2021
BUY
$7.25 - $10.99 $83,404 - $126,428
11,504 Added 0.96%
1,215,529 $12 Million
Q1 2021

May 12, 2021
SELL
$4.57 - $11.18 $298,178 - $729,461
-65,247 Reduced 5.14%
1,204,025 $11.8 Million
Q4 2020

Feb 11, 2021
SELL
$3.73 - $5.6 $165,783 - $248,897
-44,446 Reduced 3.38%
1,269,272 $5.65 Million
Q3 2020

Nov 16, 2020
BUY
$4.32 - $11.7 $367,528 - $995,389
85,076 Added 6.92%
1,313,718 $5.68 Million
Q2 2020

Aug 14, 2020
BUY
$2.94 - $9.1 $365,003 - $1.13 Million
124,151 Added 11.24%
1,228,642 $10.9 Million
Q1 2020

May 14, 2020
BUY
$2.27 - $6.2 $75,057 - $205,003
33,065 Added 3.09%
1,104,491 $3.9 Million
Q4 2019

Feb 14, 2020
BUY
$3.46 - $6.93 $101,211 - $202,716
29,252 Added 2.81%
1,071,426 $6.13 Million
Q3 2019

Nov 13, 2019
BUY
$2.69 - $4.85 $811,874 - $1.46 Million
301,812 Added 40.77%
1,042,174 $3.73 Million
Q2 2019

Aug 13, 2019
SELL
$3.65 - $7.89 $94,075 - $203,356
-25,774 Reduced 3.36%
740,362 $2.95 Million
Q1 2019

May 13, 2019
SELL
$7.08 - $12.09 $83,027 - $141,779
-11,727 Reduced 1.51%
766,136 $5.6 Million
Q4 2018

Feb 12, 2019
SELL
$8.14 - $13.28 $105,103 - $171,471
-12,912 Reduced 1.63%
777,863 $7.12 Million
Q3 2018

Nov 14, 2018
BUY
$11.85 - $16.0 $477,946 - $645,328
40,333 Added 5.37%
790,775 $9.81 Million
Q2 2018

Sep 18, 2018
SELL
$15.15 - $20.75 $50,252 - $68,827
-3,317 Reduced 0.44%
750,442 $11.4 Million
Q2 2018

Aug 14, 2018
BUY
$15.15 - $20.75 $1.06 Million - $1.45 Million
69,994 Added 10.24%
753,759 $11.5 Million
Q1 2018

May 09, 2018
BUY
$14.65 - $19.9 $11,807 - $16,039
806 Added 0.12%
683,765 $13.6 Million
Q4 2017

Feb 14, 2018
SELL
$17.3 - $24.08 $95,686 - $133,186
-5,531 Reduced 0.8%
682,959 $12.8 Million
Q3 2017

Nov 13, 2017
BUY
$15.2 - $21.5 $10.5 Million - $14.8 Million
688,490
688,490 $14.8 Million

Others Institutions Holding DVAX

# of Institutions
273
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.6B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email